<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">cardiovascular</journal-id><journal-title-group><journal-title xml:lang="ru">Кардиоваскулярная терапия и профилактика</journal-title><trans-title-group xml:lang="en"><trans-title>Cardiovascular Therapy and Prevention</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1728-8800</issn><issn pub-type="epub">2619-0125</issn><publisher><publisher-name>«SILICEA-POLIGRAF» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15829/1728-8800-2025-4282</article-id><article-id custom-type="edn" pub-id-type="custom">JCUDHI</article-id><article-id custom-type="elpub" pub-id-type="custom">cardiovascular-4282</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ФАКТОРЫ РИСКА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ФАКТОРЫ РИСКА</subject></subj-group></article-categories><title-group><article-title>Диастолическая функция у женщин среднего возраста с наличием факторов неблагоприятного течения и исходов в анамнезе беременности</article-title><trans-title-group xml:lang="en"><trans-title>Diastolic function in middle-aged women with factors of unfavorable course and outcomes of pregnancy</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3274-2290</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шперлинг</surname><given-names>М. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Shperling .</surname><given-names>M. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Шперлинг Максим Игоревич — м.н.с. отдела фундаментальных и прикладных аспектов ожирения</p><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><email xlink:type="simple">MaxCardio@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0008-3682-3216</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Косулина</surname><given-names>В. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Kosulina</surname><given-names>V. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Косулина Василиса Михайловна — клинический ординатор</p><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><email xlink:type="simple">vasilisa.kosulina@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5384-3795</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Джиоева</surname><given-names>О. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Dzhioeva</surname><given-names>O. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Джиоева Ольга Николаевна — д.м.н., в.н.с., руководитель лаборатории кардиовизуализации, вегетативной регуляции и сомнологии</p><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><email xlink:type="simple">dzhioevaon@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4453-8430</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Драпкина</surname><given-names>О. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Drapkina</surname><given-names>O. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Драпкина Ольга Михайловна — д.м.н., профессор, академик РАН, директор</p><p>Москва</p><p> </p></bio><bio xml:lang="en"><p>Moscow</p></bio><email xlink:type="simple">Info@gnicpm.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ "Национальный медицинский исследовательский центр терапии и профилактической медицины" Минздрава России</institution></aff><aff xml:lang="en"><institution>National Medical Research Center for Therapy and Preventive Medicine</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>20</day><month>04</month><year>2025</year></pub-date><volume>24</volume><issue>3</issue><fpage>4282</fpage><lpage>4282</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Шперлинг М.И., Косулина В.М., Джиоева О.Н., Драпкина О.М., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Шперлинг М.И., Косулина В.М., Джиоева О.Н., Драпкина О.М.</copyright-holder><copyright-holder xml:lang="en">Shperling . M.I., Kosulina V.M., Dzhioeva O.N., Drapkina O.M.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://cardiovascular.elpub.ru/jour/article/view/4282">https://cardiovascular.elpub.ru/jour/article/view/4282</self-uri><abstract><sec><title>Цель</title><p>Цель. Оценить параметры диастолической функции левого желудочка у женщин среднего возраста в ассоциации с наличием факторов в анамнезе беременности.</p></sec><sec><title>Материал и методы</title><p>Материал и методы. Обследовано 102 женщины в возрасте 45-59 лет с наличием минимум одной завершенной беременности в анамнезе. Пациенткам выполнялась трансторакальная эхокардиография (ЭхоКГ) с последующим интервьюированием для выявления факторов неблагоприятного течения и исходов беременности в анамнезе. Оценивались частота выявления факторов неблагоприятного течения и исходов беременности, различия параметров диастолической функции в зависимости от наличия или отсутствия конкретных факторов неблагоприятного течения и исходов беременности, а также связь факторов с наличием диастолической дисфункции (ДД).</p></sec><sec><title>Результаты</title><p>Результаты. Наиболее выраженные изменения в количественных показателях диастолической функции отмечены в отношении гипертензивных осложнений: септальная пиковая скорость движения кольца митрального клапана (e’септ) была значимо ниже в группе с артериальной гипертензией (АГ) в анамнезе беременности (7,3±1,5 vs 8,6±1,6 см/сек, p=0,006), соотношение пиковой скорости трансмитрального потока к средней скорости движения кольца митрального клапана (E/e’ср) оказалось значимо выше в группе с АГ в анамнезе беременности — 9,1±2,4 vs 7,2±1,7 (p=0,006). Обнаружены ассоциации между ДД и АГ (отношение шансов (OR — odds ratio) =3,10 (95% доверительный интервал (ДИ): 1,19-8,01, p=0,02), протеинурией (OR=4,69 (95% ДИ: 1,15-17,39, p=0,04)), курением во время беременности (OR =3,91 (95% ДИ: 1,16-12,89, p=0,03)).</p></sec><sec><title>Заключение</title><p>Заключение. Наиболее выраженные изменения в показателях диастолической функции отмечены в группе женщин, имевших анамнез гипертензивных осложнений во время беременности. Результаты исследования позволяют предположить наличие ассоциации между рядом факторов неблагоприятного течения и исходов беременности (АГ, протеинурия, курение) и наличием ДД. </p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Aim</title><p>Aim. To assess the parameters of left ventricular diastolic function in middle-aged women in association with unfavorable factors of pregnancy.</p></sec><sec><title>Material and methods</title><p>Material and methods. A total of 102 women aged 45-59 years with at least one completed pregnancy were examined. The patients underwent transthoracic echocardiography followed by interviewing to identify factors of unfavorable course and outcomes of pregnancy. The detection rate of factors of unfavorable pregnancy course and outcomes, differences in diastolic function parameters depending on specific factors of unfavorable course and outcomes of pregnancy, as well as the relationship of factors with diastolic dysfunction (DD) were assessed.</p></sec><sec><title>Results</title><p>Results. The most pronounced changes in diastolic function quan­titative values were noted in relation to following hypertensive com­plications: septal peak mitral annular velocity (e’sept) was significantly lower in the group with hypertension (HTN) in pregnancy (7,3±1,5 vs 8,6±1,6 cm/sec, p=0,006); the ratio of peak transmitral flow velocity to mean mitral annular velocity (E/e’ mean) was significantly higher in the group with HTN in pregnancy — 9,1±2,4 vs 7,2±1,7 (p=0,006). Associations were found between DD and HTN (odds ratio (OR) =3,10 (95% confidence interval (CI): 1,19-8,01, p=0,02)), proteinuria (OR =4,69 (95% CI: 1,15-17,39, p=0,04)), smoking during pregnancy (OR =3,91 (95% CI: 1,16-12,89, p=0,03)).</p></sec><sec><title>Conclusion</title><p>Conclusion. The most pronounced changes in diastolic function parameters were noted in the group of women with hypertensive complications during pregnancy. The results of the study suggest an association between a number of factors of unfavorable pregnancy course and outcomes (hypertension, proteinuria, smoking) and DD.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>осложнения беременности</kwd><kwd>артериальная гипертензия беременных</kwd><kwd>диастолическая дисфункция</kwd><kwd>сердечная недостаточность</kwd><kwd>сердечная недостаточность с сохраненной фракцией выброса</kwd></kwd-group><kwd-group xml:lang="en"><kwd>pregnancy complications</kwd><kwd>gestational hypertension</kwd><kwd>dia­stolic dysfunction</kwd><kwd>heart failure</kwd><kwd>heart failure with preserved ejection frac­tion</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Mancia G, Kreutz R, Brunström M, et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens. 2023;41(12):1874. doi:10.1097/HJH.0000000000003480.</mixed-citation><mixed-citation xml:lang="en">Mancia G, Kreutz R, Brunström M, et al. 2023 ESH Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens. 2023;41(12):1874. doi:10.1097/HJH.0000000000003480.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Briller JE, Mogos MF, Muchira JM, et al. Pregnancy Associated Heart Failure With Preserved Ejection Fraction: Risk Factors and Maternal Morbidity. J Card Fail. 2021;27(2):143-52. doi:10.1016/j.cardfail.2020.12.020.</mixed-citation><mixed-citation xml:lang="en">Briller JE, Mogos MF, Muchira JM, et al. Pregnancy Associated Heart Failure With Preserved Ejection Fraction: Risk Factors and Maternal Morbidity. J Card Fail. 2021;27(2):143-52. doi:10.1016/j.cardfail.2020.12.020.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Hansen AL, Søndergaard MM, Hlatky MA, et al. Adverse Pregnancy Outcomes and Incident Heart Failure in the Women’s Health Initiative. JAMA Netw Open. 2021;4(12):e2138071. doi:10.1001/jamanetworkopen.2021.38071.</mixed-citation><mixed-citation xml:lang="en">Hansen AL, Søndergaard MM, Hlatky MA, et al. Adverse Pregnancy Outcomes and Incident Heart Failure in the Women’s Health Initiative. JAMA Netw Open. 2021;4(12):e2138071. doi:10.1001/jamanetworkopen.2021.38071.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Шперлинг М.И., Мольс А.А., Косулина В.М. и др. Гендерные особенности сердечной недостаточности с сохраненной фракцией выброса у женщин: акцент на факторы беременности. Кардиоваскулярная терапия и профилактика. 2024;23(8):4006. doi:10.15829/1728-88002024-4006.</mixed-citation><mixed-citation xml:lang="en">Shperling MI, Mols AA, Kosulina VM, et al. Gender-specific charac-teristics of heart failure with preserved ejection fraction in women: focus on pregnancy factors. Cardiovascular Therapy and Prevention. 2024;23(8):4006. (In Russ.) doi:10.15829/1728-8800-2024-4006.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Redfield MM, Borlaug BA. Heart Failure With Preserved Ejection Fraction: A Review. JAMA. 2023;329(10):827-38. doi:10.1001/jama.2023.2020.</mixed-citation><mixed-citation xml:lang="en">Redfield MM, Borlaug BA. Heart Failure With Preserved Ejection Fraction: A Review. JAMA. 2023;329(10):827-38. doi:10.1001/jama.2023.2020.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Obokata M, Reddy YNV, Borlaug BA. Diastolic Dysfunction and Heart Failure With Preserved Ejection Fraction: Understanding Mechanisms by Using Noninvasive Methods. JACC Cardiovasc Imaging. 2020;13(1 Pt 2):245-57. doi:10.1016/j.jcmg.2018.12.034.</mixed-citation><mixed-citation xml:lang="en">Obokata M, Reddy YNV, Borlaug BA. Diastolic Dysfunction and Heart Failure With Preserved Ejection Fraction: Understanding Mechanisms by Using Noninvasive Methods. JACC Cardiovasc Imaging. 2020;13(1 Pt 2):245-57. doi:10.1016/j.jcmg.2018.12.034.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Stewart S, Playford D, Scalia GM, et al. Ejection fraction and mortality: a nationwide register-based cohort study of 499 153 women and men. Eur J Heart Fail. 2021;23(3):406-16. doi:10.1002/ejhf.2047.</mixed-citation><mixed-citation xml:lang="en">Stewart S, Playford D, Scalia GM, et al. Ejection fraction and mor-tality: a nationwide register-based cohort study of 499 153 women and men. Eur J Heart Fail. 2021;23(3):406-16. doi:10.1002/ejhf.2047.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Галявич А.С., Терещенко С.Н., Ускач Т.М. и др. Хроническая сердечная недостаточность. Клинические рекомендации 2024. Российский кардиологический журнал. 2024;29(11):6162. doi:10.15829/1560-4071-2024-6162. EDN: WKIDLJ</mixed-citation><mixed-citation xml:lang="en">Galyavich AS, Tereshchenko SN, Uskach TM, et al. Clinical practice guidelines for Chronic heart failure. Russian Journal of Cardiology. 2024;29(11):6162. (In Russ.) doi:10.15829/1560-4071-2024-6162. EDN WKIDLJ.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Cohen JB, Schrauben SJ, Zhao L, et al. Clinical Phenogroups in Heart Failure With Preserved Ejection Fraction: Detailed Phenotypes, Prognosis, and Response to Spironolactone. JACC Heart Fail. 2020;8(3):172-84. doi:10.1016/j.jchf.2019.09.009.</mixed-citation><mixed-citation xml:lang="en">Cohen JB, Schrauben SJ, Zhao L, et al. Clinical Phenogroups in Heart Failure With Preserved Ejection Fraction: Detailed Phenotypes, Prognosis, and Response to Spironolactone. JACC Heart Fail. 2020;8(3):172-84. doi:10.1016/j.jchf.2019.09.009.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Smiseth OA, Morris DA, Cardim N, et al. Multimodality imaging in patients with heart failure and preserved ejection fraction: an expert consensus document of the European Association of Cardiovascular Imaging. Eur Heart J – Cardiovasc Imaging. 2022;23(2):e34-e61. doi:10.1093/ehjci/jeab154.</mixed-citation><mixed-citation xml:lang="en">Smiseth OA, Morris DA, Cardim N, et al. Multimodality imaging in patients with heart failure and preserved ejection fraction: an expert consensus document of the European Association of Cardiovascular Imaging. Eur Heart J — Cardiovasc Imaging. 2022;23(2):e34-e61. doi:10.1093/ehjci/jeab154.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Nagueh SF, Smiseth OA, Appleton CP, et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2016;29(4):277-314. doi:10.1016/j.echo.2016.01.011.</mixed-citation><mixed-citation xml:lang="en">Nagueh SF, Smiseth OA, Appleton CP, et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocar-diography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2016;29(4):277-314. doi:10.1016/j.echo.2016.01.011.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Magliano DJ, Boyko EJ, IDF Diabetes Atlas 10th edition scientific committee. IDF DIABETES ATLAS. 10th ed. International Diabetes Federation. 2021. ISBN-13: 978-2-930229-98-0.</mixed-citation><mixed-citation xml:lang="en">Magliano DJ, Boyko EJ, IDF Diabetes Atlas 10th edition scientific committee. IDF DIABETES ATLAS. 10th ed. International Diabetes Federation. 2021. ISBN-13: 978-2-930229-98-0.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Wang H, Li N, Chivese T, et al. IDF Diabetes Atlas: Estimation of Global and Regional Gestational Diabetes Mellitus Prevalence for 2021 by International Association of Diabetes in Pregnancy Study Group’s Criteria. Diabetes Res Clin Pract. 2022;183:109050. doi:10.1016/j.diabres.2021.109050.</mixed-citation><mixed-citation xml:lang="en">Wang H, Li N, Chivese T, et al. IDF Diabetes Atlas: Estimation of Global and Regional Gestational Diabetes Mellitus Prevalence for 2021 by International Association of Diabetes in Pregnancy Study Group’s Criteria. Diabetes Res Clin Pract. 2022;183:109050. doi:10.1016/j.diabres.2021.109050.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy: a World Health Organization Guideline. Diabetes Res Clin Pract. 2014;103(3):341-63. doi:10.1016/j.diabres.2013.10.012.</mixed-citation><mixed-citation xml:lang="en">Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy: a World Health Organization Guideline. Dia¬betes Res Clin Pract. 2014;103(3):341-63. doi:10.1016/j.diabres.2013.10.012.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">HAPO Study Cooperative Research Group, Metzger BE, Lowe LP, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358(19):1991-2002. doi:10.1056/NEJMoa0707943.</mixed-citation><mixed-citation xml:lang="en">HAPO Study Cooperative Research Group, Metzger BE, Lowe LP, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358(19):1991-2002. doi:10.1056/NEJMoa0707943.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Coughlin SS. Recall bias in epidemiologic studies. J Clin Epidemiol. 1990;43(1):87-91. doi:10.1016/0895-4356(90)90060-3.</mixed-citation><mixed-citation xml:lang="en">Coughlin SS. Recall bias in epidemiologic studies. J Clin Epidemiol. 1990;43(1):87-91. doi:10.1016/0895-4356(90)90060-3.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
